nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Carmustine—melanoma	0.144	0.229	CbGbCtD
Rotigotine—CYP1A2—Vemurafenib—melanoma	0.114	0.181	CbGbCtD
Rotigotine—CYP3A4—Temozolomide—melanoma	0.109	0.173	CbGbCtD
Rotigotine—CYP2D6—Vemurafenib—melanoma	0.094	0.149	CbGbCtD
Rotigotine—CYP1A2—Dacarbazine—melanoma	0.0874	0.139	CbGbCtD
Rotigotine—CYP3A4—Vemurafenib—melanoma	0.0598	0.095	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—melanoma	0.0205	0.0326	CbGbCtD
Rotigotine—Malignant melanoma—Vemurafenib—melanoma	0.0128	0.0646	CcSEcCtD
Rotigotine—Musculoskeletal pain—Vemurafenib—melanoma	0.00338	0.0171	CcSEcCtD
Rotigotine—Dysaesthesia—Docetaxel—melanoma	0.00263	0.0133	CcSEcCtD
Rotigotine—Prurigo—Docetaxel—melanoma	0.00246	0.0124	CcSEcCtD
Rotigotine—DRD5—eyelid—melanoma	0.00235	0.737	CbGeAlD
Rotigotine—Aggression—Bleomycin—melanoma	0.0023	0.0116	CcSEcCtD
Rotigotine—Skin exfoliation—Bleomycin—melanoma	0.00193	0.00975	CcSEcCtD
Rotigotine—Weight decreased—Vemurafenib—melanoma	0.0019	0.00957	CcSEcCtD
Rotigotine—Infestation NOS—Vemurafenib—melanoma	0.00187	0.00943	CcSEcCtD
Rotigotine—Infestation—Vemurafenib—melanoma	0.00187	0.00943	CcSEcCtD
Rotigotine—Musculoskeletal pain—Temozolomide—melanoma	0.00173	0.00872	CcSEcCtD
Rotigotine—Skin exfoliation—Carmustine—melanoma	0.00169	0.00851	CcSEcCtD
Rotigotine—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00168	0.00849	CcSEcCtD
Rotigotine—Laryngeal pain—Docetaxel—melanoma	0.00167	0.00841	CcSEcCtD
Rotigotine—Oedema peripheral—Vemurafenib—melanoma	0.00165	0.00834	CcSEcCtD
Rotigotine—Haemoglobin decreased—Docetaxel—melanoma	0.00165	0.00833	CcSEcCtD
Rotigotine—Connective tissue disorder—Vemurafenib—melanoma	0.00165	0.00832	CcSEcCtD
Rotigotine—Disorientation—Bleomycin—melanoma	0.00164	0.00829	CcSEcCtD
Rotigotine—Skin exfoliation—Temozolomide—melanoma	0.00163	0.00823	CcSEcCtD
Rotigotine—Abnormal vision—Carmustine—melanoma	0.00154	0.00778	CcSEcCtD
Rotigotine—Angiopathy—Vemurafenib—melanoma	0.00152	0.00768	CcSEcCtD
Rotigotine—Mediastinal disorder—Vemurafenib—melanoma	0.00151	0.00763	CcSEcCtD
Rotigotine—Abnormal vision—Temozolomide—melanoma	0.00149	0.00752	CcSEcCtD
Rotigotine—Malnutrition—Vemurafenib—melanoma	0.00146	0.00737	CcSEcCtD
Rotigotine—Erythema—Vemurafenib—melanoma	0.00146	0.00737	CcSEcCtD
Rotigotine—Swelling—Carmustine—melanoma	0.00145	0.00734	CcSEcCtD
Rotigotine—Lethargy—Dactinomycin—melanoma	0.0014	0.00706	CcSEcCtD
Rotigotine—Nasal congestion—Temozolomide—melanoma	0.00136	0.00687	CcSEcCtD
Rotigotine—Hot flush—Temozolomide—melanoma	0.00133	0.00669	CcSEcCtD
Rotigotine—Menopausal symptoms—Temozolomide—melanoma	0.00131	0.00663	CcSEcCtD
Rotigotine—Cough—Vemurafenib—melanoma	0.00128	0.00643	CcSEcCtD
Rotigotine—Arthralgia—Vemurafenib—melanoma	0.00124	0.00628	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00124	0.00623	CcSEcCtD
Rotigotine—Infection—Vemurafenib—melanoma	0.00118	0.00598	CcSEcCtD
Rotigotine—Inflammation—Docetaxel—melanoma	0.00117	0.00591	CcSEcCtD
Rotigotine—Nervous system disorder—Vemurafenib—melanoma	0.00117	0.0059	CcSEcCtD
Rotigotine—Skin disorder—Vemurafenib—melanoma	0.00116	0.00584	CcSEcCtD
Rotigotine—Weight decreased—Bleomycin—melanoma	0.00115	0.0058	CcSEcCtD
Rotigotine—Breast disorder—Temozolomide—melanoma	0.00112	0.00565	CcSEcCtD
Rotigotine—Hypotension—Vemurafenib—melanoma	0.00111	0.00562	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00109	0.00548	CcSEcCtD
Rotigotine—Skin exfoliation—Docetaxel—melanoma	0.00108	0.00547	CcSEcCtD
Rotigotine—Fluid retention—Docetaxel—melanoma	0.00108	0.00544	CcSEcCtD
Rotigotine—Sweating increased—Temozolomide—melanoma	0.00104	0.00527	CcSEcCtD
Rotigotine—Decreased appetite—Vemurafenib—melanoma	0.00104	0.00523	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00103	0.00519	CcSEcCtD
Rotigotine—Fatigue—Vemurafenib—melanoma	0.00103	0.00519	CcSEcCtD
Rotigotine—Constipation—Vemurafenib—melanoma	0.00102	0.00515	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Temozolomide—melanoma	0.000996	0.00503	CcSEcCtD
Rotigotine—Erectile dysfunction—Temozolomide—melanoma	0.000987	0.00498	CcSEcCtD
Rotigotine—Depression—Carmustine—melanoma	0.000986	0.00497	CcSEcCtD
Rotigotine—Weight increased—Temozolomide—melanoma	0.000975	0.00492	CcSEcCtD
Rotigotine—Weight decreased—Temozolomide—melanoma	0.00097	0.00489	CcSEcCtD
Rotigotine—Infestation NOS—Temozolomide—melanoma	0.000956	0.00482	CcSEcCtD
Rotigotine—Infestation—Temozolomide—melanoma	0.000956	0.00482	CcSEcCtD
Rotigotine—Depression—Temozolomide—melanoma	0.000953	0.00481	CcSEcCtD
Rotigotine—Swelling—Docetaxel—melanoma	0.000935	0.00472	CcSEcCtD
Rotigotine—Sinusitis—Temozolomide—melanoma	0.000897	0.00452	CcSEcCtD
Rotigotine—Erythema—Bleomycin—melanoma	0.000885	0.00447	CcSEcCtD
Rotigotine—Hallucination—Carmustine—melanoma	0.000883	0.00446	CcSEcCtD
Rotigotine—Hot flush—Docetaxel—melanoma	0.000882	0.00445	CcSEcCtD
Rotigotine—Hypersensitivity—Vemurafenib—melanoma	0.000879	0.00443	CcSEcCtD
Rotigotine—Oedema peripheral—Carmustine—melanoma	0.000874	0.00441	CcSEcCtD
Rotigotine—Menopausal symptoms—Docetaxel—melanoma	0.000874	0.00441	CcSEcCtD
Rotigotine—Connective tissue disorder—Carmustine—melanoma	0.000872	0.0044	CcSEcCtD
Rotigotine—Asthenia—Vemurafenib—melanoma	0.000856	0.00432	CcSEcCtD
Rotigotine—Visual impairment—Carmustine—melanoma	0.000855	0.00432	CcSEcCtD
Rotigotine—Hallucination—Temozolomide—melanoma	0.000854	0.00431	CcSEcCtD
Rotigotine—Oedema peripheral—Temozolomide—melanoma	0.000845	0.00426	CcSEcCtD
Rotigotine—Pruritus—Vemurafenib—melanoma	0.000844	0.00426	CcSEcCtD
Rotigotine—Connective tissue disorder—Temozolomide—melanoma	0.000843	0.00425	CcSEcCtD
Rotigotine—Lethargy—Docetaxel—melanoma	0.000842	0.00425	CcSEcCtD
Rotigotine—Visual impairment—Temozolomide—melanoma	0.000827	0.00417	CcSEcCtD
Rotigotine—Erythema—Dactinomycin—melanoma	0.000826	0.00417	CcSEcCtD
Rotigotine—Ill-defined disorder—Bleomycin—melanoma	0.000821	0.00414	CcSEcCtD
Rotigotine—Diarrhoea—Vemurafenib—melanoma	0.000816	0.00412	CcSEcCtD
Rotigotine—Tinnitus—Temozolomide—melanoma	0.0008	0.00404	CcSEcCtD
Rotigotine—Malaise—Bleomycin—melanoma	0.000798	0.00403	CcSEcCtD
Rotigotine—Dizziness—Vemurafenib—melanoma	0.000789	0.00398	CcSEcCtD
Rotigotine—Angiopathy—Temozolomide—melanoma	0.000778	0.00393	CcSEcCtD
Rotigotine—Mental disorder—Carmustine—melanoma	0.000778	0.00392	CcSEcCtD
Rotigotine—Immune system disorder—Temozolomide—melanoma	0.000775	0.00391	CcSEcCtD
Rotigotine—Mediastinal disorder—Temozolomide—melanoma	0.000773	0.0039	CcSEcCtD
Rotigotine—Erythema—Carmustine—melanoma	0.000773	0.0039	CcSEcCtD
Rotigotine—Malnutrition—Carmustine—melanoma	0.000773	0.0039	CcSEcCtD
Rotigotine—Cough—Bleomycin—melanoma	0.000773	0.0039	CcSEcCtD
Rotigotine—Ill-defined disorder—Dactinomycin—melanoma	0.000766	0.00387	CcSEcCtD
Rotigotine—Vomiting—Vemurafenib—melanoma	0.000758	0.00383	CcSEcCtD
Rotigotine—Orthostatic hypotension—Docetaxel—melanoma	0.000753	0.0038	CcSEcCtD
Rotigotine—Rash—Vemurafenib—melanoma	0.000752	0.00379	CcSEcCtD
Rotigotine—Mental disorder—Temozolomide—melanoma	0.000752	0.00379	CcSEcCtD
Rotigotine—Dermatitis—Vemurafenib—melanoma	0.000751	0.00379	CcSEcCtD
Rotigotine—Headache—Vemurafenib—melanoma	0.000747	0.00377	CcSEcCtD
Rotigotine—Malnutrition—Temozolomide—melanoma	0.000747	0.00377	CcSEcCtD
Rotigotine—Erythema—Temozolomide—melanoma	0.000747	0.00377	CcSEcCtD
Rotigotine—Breast disorder—Docetaxel—melanoma	0.000745	0.00376	CcSEcCtD
Rotigotine—Discomfort—Bleomycin—melanoma	0.000745	0.00376	CcSEcCtD
Rotigotine—Malaise—Dactinomycin—melanoma	0.000745	0.00376	CcSEcCtD
Rotigotine—Nasopharyngitis—Docetaxel—melanoma	0.000737	0.00372	CcSEcCtD
Rotigotine—Confusional state—Bleomycin—melanoma	0.000729	0.00368	CcSEcCtD
Rotigotine—Tremor—Carmustine—melanoma	0.000724	0.00365	CcSEcCtD
Rotigotine—Infection—Bleomycin—melanoma	0.000718	0.00362	CcSEcCtD
Rotigotine—Agitation—Carmustine—melanoma	0.00071	0.00358	CcSEcCtD
Rotigotine—Nausea—Vemurafenib—melanoma	0.000708	0.00357	CcSEcCtD
Rotigotine—Tremor—Temozolomide—melanoma	0.0007	0.00353	CcSEcCtD
Rotigotine—Discomfort—Dactinomycin—melanoma	0.000695	0.0035	CcSEcCtD
Rotigotine—Ill-defined disorder—Temozolomide—melanoma	0.000693	0.0035	CcSEcCtD
Rotigotine—Anorexia—Bleomycin—melanoma	0.000689	0.00347	CcSEcCtD
Rotigotine—Agitation—Temozolomide—melanoma	0.000686	0.00346	CcSEcCtD
Rotigotine—Angioedema—Temozolomide—melanoma	0.000682	0.00344	CcSEcCtD
Rotigotine—Hypotension—Bleomycin—melanoma	0.000675	0.00341	CcSEcCtD
Rotigotine—Malaise—Temozolomide—melanoma	0.000673	0.0034	CcSEcCtD
Rotigotine—Vertigo—Temozolomide—melanoma	0.000671	0.00339	CcSEcCtD
Rotigotine—Infection—Dactinomycin—melanoma	0.000669	0.00338	CcSEcCtD
Rotigotine—Hypertension—Carmustine—melanoma	0.000667	0.00337	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000658	0.00332	CcSEcCtD
Rotigotine—Cough—Temozolomide—melanoma	0.000652	0.00329	CcSEcCtD
Rotigotine—Paraesthesia—Bleomycin—melanoma	0.000649	0.00327	CcSEcCtD
Rotigotine—Weight increased—Docetaxel—melanoma	0.000649	0.00327	CcSEcCtD
Rotigotine—Weight decreased—Docetaxel—melanoma	0.000645	0.00325	CcSEcCtD
Rotigotine—Hypertension—Temozolomide—melanoma	0.000645	0.00325	CcSEcCtD
Rotigotine—Anorexia—Dactinomycin—melanoma	0.000642	0.00324	CcSEcCtD
Rotigotine—Confusional state—Carmustine—melanoma	0.000636	0.00321	CcSEcCtD
Rotigotine—Arthralgia—Temozolomide—melanoma	0.000636	0.00321	CcSEcCtD
Rotigotine—Infestation NOS—Docetaxel—melanoma	0.000635	0.00321	CcSEcCtD
Rotigotine—Infestation—Docetaxel—melanoma	0.000635	0.00321	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000631	0.00319	CcSEcCtD
Rotigotine—Discomfort—Temozolomide—melanoma	0.000628	0.00317	CcSEcCtD
Rotigotine—Decreased appetite—Bleomycin—melanoma	0.000628	0.00317	CcSEcCtD
Rotigotine—Infection—Carmustine—melanoma	0.000627	0.00316	CcSEcCtD
Rotigotine—Dry mouth—Temozolomide—melanoma	0.000622	0.00314	CcSEcCtD
Rotigotine—Pain—Bleomycin—melanoma	0.000618	0.00312	CcSEcCtD
Rotigotine—Confusional state—Temozolomide—melanoma	0.000615	0.0031	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000614	0.0031	CcSEcCtD
Rotigotine—Infection—Temozolomide—melanoma	0.000605	0.00305	CcSEcCtD
Rotigotine—Anorexia—Carmustine—melanoma	0.000601	0.00303	CcSEcCtD
Rotigotine—Nervous system disorder—Temozolomide—melanoma	0.000598	0.00302	CcSEcCtD
Rotigotine—Feeling abnormal—Bleomycin—melanoma	0.000595	0.003	CcSEcCtD
Rotigotine—Skin disorder—Temozolomide—melanoma	0.000592	0.00299	CcSEcCtD
Rotigotine—Hypotension—Carmustine—melanoma	0.000589	0.00297	CcSEcCtD
Rotigotine—Hyperhidrosis—Temozolomide—melanoma	0.000589	0.00297	CcSEcCtD
Rotigotine—Decreased appetite—Dactinomycin—melanoma	0.000586	0.00296	CcSEcCtD
Rotigotine—Fatigue—Dactinomycin—melanoma	0.000581	0.00293	CcSEcCtD
Rotigotine—Anorexia—Temozolomide—melanoma	0.000581	0.00293	CcSEcCtD
Rotigotine—Pain—Dactinomycin—melanoma	0.000576	0.00291	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Carmustine—melanoma	0.000575	0.0029	CcSEcCtD
Rotigotine—Urticaria—Bleomycin—melanoma	0.000574	0.0029	CcSEcCtD
Rotigotine—Insomnia—Carmustine—melanoma	0.00057	0.00288	CcSEcCtD
Rotigotine—Paraesthesia—Carmustine—melanoma	0.000566	0.00286	CcSEcCtD
Rotigotine—Oedema peripheral—Docetaxel—melanoma	0.000562	0.00284	CcSEcCtD
Rotigotine—Somnolence—Carmustine—melanoma	0.000561	0.00283	CcSEcCtD
Rotigotine—Connective tissue disorder—Docetaxel—melanoma	0.000561	0.00283	CcSEcCtD
Rotigotine—Feeling abnormal—Dactinomycin—melanoma	0.000555	0.0028	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000555	0.0028	CcSEcCtD
Rotigotine—Insomnia—Temozolomide—melanoma	0.000551	0.00278	CcSEcCtD
Rotigotine—Visual impairment—Docetaxel—melanoma	0.00055	0.00277	CcSEcCtD
Rotigotine—Decreased appetite—Carmustine—melanoma	0.000548	0.00277	CcSEcCtD
Rotigotine—Paraesthesia—Temozolomide—melanoma	0.000547	0.00276	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Carmustine—melanoma	0.000544	0.00275	CcSEcCtD
Rotigotine—Somnolence—Temozolomide—melanoma	0.000542	0.00273	CcSEcCtD
Rotigotine—Pain—Carmustine—melanoma	0.000539	0.00272	CcSEcCtD
Rotigotine—Constipation—Carmustine—melanoma	0.000539	0.00272	CcSEcCtD
Rotigotine—Dyspepsia—Temozolomide—melanoma	0.000536	0.00271	CcSEcCtD
Rotigotine—Hypersensitivity—Bleomycin—melanoma	0.000532	0.00269	CcSEcCtD
Rotigotine—Decreased appetite—Temozolomide—melanoma	0.00053	0.00267	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Temozolomide—melanoma	0.000526	0.00265	CcSEcCtD
Rotigotine—Fatigue—Temozolomide—melanoma	0.000525	0.00265	CcSEcCtD
Rotigotine—Constipation—Temozolomide—melanoma	0.000521	0.00263	CcSEcCtD
Rotigotine—Pain—Temozolomide—melanoma	0.000521	0.00263	CcSEcCtD
Rotigotine—Feeling abnormal—Carmustine—melanoma	0.00052	0.00262	CcSEcCtD
Rotigotine—Asthenia—Bleomycin—melanoma	0.000518	0.00262	CcSEcCtD
Rotigotine—Angiopathy—Docetaxel—melanoma	0.000518	0.00261	CcSEcCtD
Rotigotine—Immune system disorder—Docetaxel—melanoma	0.000515	0.0026	CcSEcCtD
Rotigotine—Mediastinal disorder—Docetaxel—melanoma	0.000514	0.00259	CcSEcCtD
Rotigotine—Pruritus—Bleomycin—melanoma	0.000511	0.00258	CcSEcCtD
Rotigotine—Feeling abnormal—Temozolomide—melanoma	0.000502	0.00253	CcSEcCtD
Rotigotine—Mental disorder—Docetaxel—melanoma	0.0005	0.00252	CcSEcCtD
Rotigotine—Erythema—Docetaxel—melanoma	0.000497	0.00251	CcSEcCtD
Rotigotine—Malnutrition—Docetaxel—melanoma	0.000497	0.00251	CcSEcCtD
Rotigotine—Hypersensitivity—Dactinomycin—melanoma	0.000496	0.0025	CcSEcCtD
Rotigotine—Urticaria—Temozolomide—melanoma	0.000484	0.00244	CcSEcCtD
Rotigotine—Asthenia—Dactinomycin—melanoma	0.000483	0.00244	CcSEcCtD
Rotigotine—Muscle spasms—Docetaxel—melanoma	0.000477	0.00241	CcSEcCtD
Rotigotine—Hypersensitivity—Carmustine—melanoma	0.000465	0.00234	CcSEcCtD
Rotigotine—Diarrhoea—Dactinomycin—melanoma	0.000461	0.00233	CcSEcCtD
Rotigotine—Vomiting—Bleomycin—melanoma	0.000459	0.00232	CcSEcCtD
Rotigotine—Rash—Bleomycin—melanoma	0.000456	0.0023	CcSEcCtD
Rotigotine—Dermatitis—Bleomycin—melanoma	0.000455	0.0023	CcSEcCtD
Rotigotine—Asthenia—Carmustine—melanoma	0.000452	0.00228	CcSEcCtD
Rotigotine—Hypersensitivity—Temozolomide—melanoma	0.000449	0.00227	CcSEcCtD
Rotigotine—Syncope—Docetaxel—melanoma	0.000445	0.00225	CcSEcCtD
Rotigotine—Asthenia—Temozolomide—melanoma	0.000437	0.00221	CcSEcCtD
Rotigotine—Loss of consciousness—Docetaxel—melanoma	0.000436	0.0022	CcSEcCtD
Rotigotine—Cough—Docetaxel—melanoma	0.000433	0.00219	CcSEcCtD
Rotigotine—Diarrhoea—Carmustine—melanoma	0.000432	0.00218	CcSEcCtD
Rotigotine—Pruritus—Temozolomide—melanoma	0.000431	0.00218	CcSEcCtD
Rotigotine—Nausea—Bleomycin—melanoma	0.000429	0.00217	CcSEcCtD
Rotigotine—Hypertension—Docetaxel—melanoma	0.000429	0.00216	CcSEcCtD
Rotigotine—Vomiting—Dactinomycin—melanoma	0.000428	0.00216	CcSEcCtD
Rotigotine—Rash—Dactinomycin—melanoma	0.000425	0.00214	CcSEcCtD
Rotigotine—Arthralgia—Docetaxel—melanoma	0.000423	0.00213	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00042	0.00212	CcSEcCtD
Rotigotine—Dizziness—Carmustine—melanoma	0.000417	0.0021	CcSEcCtD
Rotigotine—Diarrhoea—Temozolomide—melanoma	0.000417	0.0021	CcSEcCtD
Rotigotine—Dry mouth—Docetaxel—melanoma	0.000413	0.00209	CcSEcCtD
Rotigotine—Confusional state—Docetaxel—melanoma	0.000409	0.00206	CcSEcCtD
Rotigotine—Dizziness—Temozolomide—melanoma	0.000403	0.00203	CcSEcCtD
Rotigotine—Infection—Docetaxel—melanoma	0.000403	0.00203	CcSEcCtD
Rotigotine—Vomiting—Carmustine—melanoma	0.000401	0.00202	CcSEcCtD
Rotigotine—Nausea—Dactinomycin—melanoma	0.0004	0.00202	CcSEcCtD
Rotigotine—Shock—Docetaxel—melanoma	0.000399	0.00201	CcSEcCtD
Rotigotine—Rash—Carmustine—melanoma	0.000398	0.00201	CcSEcCtD
Rotigotine—Nervous system disorder—Docetaxel—melanoma	0.000397	0.00201	CcSEcCtD
Rotigotine—Dermatitis—Carmustine—melanoma	0.000397	0.002	CcSEcCtD
Rotigotine—Headache—Carmustine—melanoma	0.000395	0.00199	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—melanoma	0.000394	0.00199	CcSEcCtD
Rotigotine—Vomiting—Temozolomide—melanoma	0.000388	0.00196	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—melanoma	0.000386	0.00195	CcSEcCtD
Rotigotine—Rash—Temozolomide—melanoma	0.000384	0.00194	CcSEcCtD
Rotigotine—Dermatitis—Temozolomide—melanoma	0.000384	0.00194	CcSEcCtD
Rotigotine—Headache—Temozolomide—melanoma	0.000382	0.00193	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—melanoma	0.000379	0.00191	CcSEcCtD
Rotigotine—Nausea—Carmustine—melanoma	0.000375	0.00189	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000369	0.00186	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—melanoma	0.000367	0.00185	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—melanoma	0.000364	0.00184	CcSEcCtD
Rotigotine—Nausea—Temozolomide—melanoma	0.000362	0.00183	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—melanoma	0.00036	0.00182	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—melanoma	0.000357	0.0018	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—melanoma	0.000352	0.00178	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—melanoma	0.00035	0.00177	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—melanoma	0.000349	0.00176	CcSEcCtD
Rotigotine—Pain—Docetaxel—melanoma	0.000347	0.00175	CcSEcCtD
Rotigotine—Constipation—Docetaxel—melanoma	0.000347	0.00175	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—melanoma	0.000334	0.00169	CcSEcCtD
Rotigotine—Hypersensitivity—Docetaxel—melanoma	0.000299	0.00151	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—melanoma	0.000291	0.00147	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—melanoma	0.000287	0.00145	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—melanoma	0.000277	0.0014	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—melanoma	0.000268	0.00135	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—melanoma	0.000258	0.0013	CcSEcCtD
Rotigotine—Rash—Docetaxel—melanoma	0.000256	0.00129	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—melanoma	0.000255	0.00129	CcSEcCtD
Rotigotine—Headache—Docetaxel—melanoma	0.000254	0.00128	CcSEcCtD
Rotigotine—Nausea—Docetaxel—melanoma	0.000241	0.00121	CcSEcCtD
Rotigotine—DRD3—head—melanoma	0.000158	0.0497	CbGeAlD
Rotigotine—DRD5—head—melanoma	0.000149	0.0466	CbGeAlD
Rotigotine—DRD2—eye—melanoma	0.000118	0.0371	CbGeAlD
Rotigotine—DRD2—retina—melanoma	0.000117	0.0367	CbGeAlD
Rotigotine—DRD1—head—melanoma	0.000113	0.0356	CbGeAlD
Rotigotine—HTR1A—head—melanoma	7.42e-05	0.0233	CbGeAlD
Rotigotine—DRD2—head—melanoma	6.7e-05	0.021	CbGeAlD
Rotigotine—CYP2D6—head—melanoma	4.03e-05	0.0126	CbGeAlD
Rotigotine—DRD1—Signaling Pathways—ERBB2—melanoma	1.28e-05	7.57e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—PIK3CA—melanoma	1.28e-05	7.56e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH1—melanoma	1.28e-05	7.53e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.27e-05	7.49e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—KRAS—melanoma	1.27e-05	7.48e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CB—melanoma	1.27e-05	7.47e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ERBB2—melanoma	1.27e-05	7.47e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—KRAS—melanoma	1.27e-05	7.46e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCND1—melanoma	1.26e-05	7.43e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAP2K1—melanoma	1.26e-05	7.42e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.26e-05	7.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CD80—melanoma	1.25e-05	7.38e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CB—melanoma	1.25e-05	7.37e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CD—melanoma	1.25e-05	7.37e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KIT—melanoma	1.25e-05	7.36e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APC—melanoma	1.25e-05	7.36e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CG—melanoma	1.25e-05	7.36e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—NRAS—melanoma	1.25e-05	7.36e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CTNNB1—melanoma	1.25e-05	7.36e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1B1—melanoma	1.24e-05	7.33e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FGF2—melanoma	1.24e-05	7.31e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	1.24e-05	7.3e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGF—melanoma	1.23e-05	7.28e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—melanoma	1.22e-05	7.22e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—melanoma	1.22e-05	7.21e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1A—melanoma	1.22e-05	7.19e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—melanoma	1.22e-05	7.18e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—melanoma	1.22e-05	7.17e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NFKB1—melanoma	1.21e-05	7.14e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—melanoma	1.21e-05	7.13e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCB1—melanoma	1.21e-05	7.13e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—melanoma	1.2e-05	7.09e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGF2—melanoma	1.2e-05	7.06e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK3—melanoma	1.2e-05	7.05e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—melanoma	1.19e-05	7.04e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1B—melanoma	1.19e-05	7.01e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—melanoma	1.19e-05	7e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—melanoma	1.18e-05	6.94e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—BRAF—melanoma	1.17e-05	6.92e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1B—melanoma	1.17e-05	6.92e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—melanoma	1.17e-05	6.87e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—melanoma	1.16e-05	6.87e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—melanoma	1.16e-05	6.86e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—melanoma	1.16e-05	6.86e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—melanoma	1.16e-05	6.84e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MDM2—melanoma	1.16e-05	6.84e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—melanoma	1.16e-05	6.83e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—melanoma	1.15e-05	6.78e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—melanoma	1.15e-05	6.77e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—melanoma	1.14e-05	6.75e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1—melanoma	1.14e-05	6.74e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—melanoma	1.14e-05	6.74e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP17A1—melanoma	1.14e-05	6.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK1—melanoma	1.14e-05	6.71e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—melanoma	1.14e-05	6.71e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—melanoma	1.13e-05	6.69e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—melanoma	1.13e-05	6.66e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—melanoma	1.12e-05	6.63e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—melanoma	1.12e-05	6.63e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CTNNB1—melanoma	1.12e-05	6.63e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MDM2—melanoma	1.12e-05	6.6e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—melanoma	1.12e-05	6.6e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PRKCA—melanoma	1.11e-05	6.56e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CTNNB1—melanoma	1.11e-05	6.54e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAP2K1—melanoma	1.1e-05	6.52e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—melanoma	1.1e-05	6.51e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ERCC2—melanoma	1.1e-05	6.5e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—melanoma	1.1e-05	6.5e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—melanoma	1.1e-05	6.48e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—melanoma	1.1e-05	6.47e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—melanoma	1.1e-05	6.47e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.1e-05	6.47e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—melanoma	1.09e-05	6.46e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NFKB1—melanoma	1.09e-05	6.43e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—melanoma	1.09e-05	6.43e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—melanoma	1.09e-05	6.41e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—melanoma	1.09e-05	6.41e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—melanoma	1.09e-05	6.41e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRAS—melanoma	1.09e-05	6.4e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—melanoma	1.08e-05	6.4e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—melanoma	1.08e-05	6.39e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—melanoma	1.08e-05	6.37e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—melanoma	1.08e-05	6.36e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNA11—melanoma	1.08e-05	6.35e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—melanoma	1.08e-05	6.34e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NFKB1—melanoma	1.08e-05	6.34e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—melanoma	1.07e-05	6.34e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—melanoma	1.07e-05	6.3e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1B—melanoma	1.06e-05	6.25e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—melanoma	1.05e-05	6.22e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—FASN—melanoma	1.05e-05	6.21e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGF2—melanoma	1.05e-05	6.2e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—melanoma	1.05e-05	6.18e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—melanoma	1.05e-05	6.18e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—melanoma	1.04e-05	6.14e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK3—melanoma	1.04e-05	6.13e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—melanoma	1.04e-05	6.12e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—melanoma	1.04e-05	6.11e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC5A5—melanoma	1.04e-05	6.11e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—melanoma	1.03e-05	6.08e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—melanoma	1.03e-05	6.07e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—melanoma	1.02e-05	6.04e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1B—melanoma	1.02e-05	6.03e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—melanoma	1.01e-05	5.97e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—melanoma	1.01e-05	5.96e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—melanoma	1.01e-05	5.96e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—melanoma	1e-05	5.91e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CTNNB1—melanoma	1e-05	5.9e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—melanoma	1e-05	5.9e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GNAQ—melanoma	1e-05	5.9e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CD44—melanoma	1e-05	5.9e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—melanoma	9.96e-06	5.87e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—melanoma	9.89e-06	5.83e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK1—melanoma	9.89e-06	5.83e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—melanoma	9.89e-06	5.83e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—melanoma	9.87e-06	5.82e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MDM2—melanoma	9.83e-06	5.8e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—melanoma	9.81e-06	5.79e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—melanoma	9.79e-06	5.77e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—melanoma	9.78e-06	5.77e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRAS—melanoma	9.77e-06	5.76e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—melanoma	9.76e-06	5.75e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—melanoma	9.76e-06	5.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—melanoma	9.75e-06	5.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NFKB1—melanoma	9.71e-06	5.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—melanoma	9.69e-06	5.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—melanoma	9.66e-06	5.7e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CTNNB1—melanoma	9.66e-06	5.7e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRAS—melanoma	9.64e-06	5.68e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1B1—melanoma	9.59e-06	5.66e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—melanoma	9.57e-06	5.64e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—melanoma	9.52e-06	5.61e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—melanoma	9.5e-06	5.6e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—melanoma	9.47e-06	5.59e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—melanoma	9.44e-06	5.57e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PRKCA—melanoma	9.42e-06	5.56e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—melanoma	9.42e-06	5.55e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NFKB1—melanoma	9.37e-06	5.53e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK3—melanoma	9.36e-06	5.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ERCC2—melanoma	9.34e-06	5.51e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—melanoma	9.34e-06	5.51e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK3—melanoma	9.23e-06	5.44e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—melanoma	9.19e-06	5.42e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—melanoma	9.19e-06	5.42e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—melanoma	9.13e-06	5.39e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—melanoma	9.1e-06	5.37e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—melanoma	8.98e-06	5.29e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1B—melanoma	8.98e-06	5.29e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK1—melanoma	8.9e-06	5.25e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—melanoma	8.9e-06	5.25e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—melanoma	8.88e-06	5.24e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—melanoma	8.81e-06	5.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—melanoma	8.8e-06	5.19e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—melanoma	8.79e-06	5.18e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK1—melanoma	8.78e-06	5.18e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—melanoma	8.78e-06	5.18e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—melanoma	8.74e-06	5.16e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—melanoma	8.72e-06	5.14e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—melanoma	8.71e-06	5.14e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRAS—melanoma	8.7e-06	5.13e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—melanoma	8.58e-06	5.06e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—melanoma	8.56e-06	5.05e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—melanoma	8.5e-06	5.02e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNB1—melanoma	8.48e-06	5e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—melanoma	8.42e-06	4.97e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—melanoma	8.41e-06	4.96e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARG—melanoma	8.41e-06	4.96e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRAS—melanoma	8.4e-06	4.95e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK3—melanoma	8.33e-06	4.91e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—melanoma	8.32e-06	4.9e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—melanoma	8.3e-06	4.9e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—melanoma	8.3e-06	4.89e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—melanoma	8.29e-06	4.89e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—melanoma	8.27e-06	4.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NFKB1—melanoma	8.23e-06	4.85e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—melanoma	8.11e-06	4.78e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—melanoma	8.06e-06	4.76e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK3—melanoma	8.04e-06	4.74e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—melanoma	7.94e-06	4.68e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK1—melanoma	7.93e-06	4.68e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—melanoma	7.93e-06	4.68e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—melanoma	7.9e-06	4.66e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—melanoma	7.82e-06	4.61e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.74e-06	4.56e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—melanoma	7.72e-06	4.56e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—melanoma	7.66e-06	4.52e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK1—melanoma	7.65e-06	4.51e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—melanoma	7.65e-06	4.51e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—melanoma	7.62e-06	4.49e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—melanoma	7.6e-06	4.48e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—melanoma	7.56e-06	4.46e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—melanoma	7.49e-06	4.42e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—melanoma	7.47e-06	4.41e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—melanoma	7.47e-06	4.4e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—melanoma	7.39e-06	4.36e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—melanoma	7.38e-06	4.35e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRAS—melanoma	7.38e-06	4.35e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—melanoma	7.37e-06	4.35e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PRKCA—melanoma	7.27e-06	4.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—melanoma	7.23e-06	4.26e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ERCC2—melanoma	7.21e-06	4.25e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—melanoma	7.15e-06	4.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARG—melanoma	7.12e-06	4.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK3—melanoma	7.06e-06	4.17e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—melanoma	7.05e-06	4.16e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—melanoma	7.01e-06	4.13e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	6.88e-06	4.06e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—melanoma	6.87e-06	4.05e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—melanoma	6.84e-06	4.03e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—melanoma	6.75e-06	3.98e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK1—melanoma	6.72e-06	3.96e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—melanoma	6.72e-06	3.96e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—melanoma	6.67e-06	3.94e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—melanoma	6.66e-06	3.93e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—melanoma	6.64e-06	3.92e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—melanoma	6.61e-06	3.9e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—melanoma	6.49e-06	3.83e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—melanoma	6.43e-06	3.79e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—melanoma	6.4e-06	3.78e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—melanoma	6.37e-06	3.75e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—melanoma	6.35e-06	3.74e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—melanoma	6.31e-06	3.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—melanoma	6.23e-06	3.67e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—melanoma	6.15e-06	3.62e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—melanoma	6.09e-06	3.59e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—melanoma	5.88e-06	3.47e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—melanoma	5.83e-06	3.44e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—melanoma	5.77e-06	3.4e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—melanoma	5.69e-06	3.36e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—melanoma	5.65e-06	3.33e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—melanoma	5.64e-06	3.33e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—melanoma	5.62e-06	3.31e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—melanoma	5.6e-06	3.3e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARG—melanoma	5.5e-06	3.24e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—melanoma	5.43e-06	3.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—melanoma	5.4e-06	3.18e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—melanoma	5.16e-06	3.05e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—melanoma	5.01e-06	2.95e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—melanoma	4.94e-06	2.91e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—melanoma	4.89e-06	2.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—melanoma	4.76e-06	2.81e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—melanoma	4.36e-06	2.57e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—melanoma	4.32e-06	2.55e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—melanoma	4.07e-06	2.4e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—melanoma	3.77e-06	2.22e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—melanoma	3.45e-06	2.03e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—melanoma	3.32e-06	1.96e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—melanoma	2.82e-06	1.66e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—melanoma	2.66e-06	1.57e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—melanoma	2.17e-06	1.28e-05	CbGpPWpGaD
